The Food and Drug Administration approved Ozempic for treating patients with chronic kidney disease on Tuesday, marking the latest authorized use for Novo Nordisk’s popular drug known for ...

After battling kidney disease for decades, Kris McDonald finally got the lifeline she needed—thanks to her son. In a touching act of love and sacrifice, Aaron McDonald donated his kidney, giving ...

The Food and Drug Administration approved Novo Nordisk’s Ozempic as the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease.

Using CRISPR to correct the mutations behind polycystic kidney disease could counter some of the damage the condition causes ...

A Toledo billboard seeks a type O kidney donor to help save artist Tommy Lee Gillard, who is facing stage 5 kidney failure.

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...

Jan. 29, 2025 -- The FDA has approved Novo Nordisk's diabetes drug Ozempic to help reduce the risk of worsening kidney disease, kidney failure, and heart-related death in adults with type 2 ...

The F.D.A. based its decision to expand the approved uses of Ozempic on research showing that people with Type 2 diabetes and chronic kidney disease who took the drug had a 24 percent lower ...

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD. Menu SECTIONS. Home; Drug Monographs.